Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Treichel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Science News|July 30, 1983
Embryo transfers achieved in humansJ A Treichel
Deutsche Zahnarztliche Zeitschrift|July 1, 1990
[Axiographic irregularities in patients with different clinical function statuses]B Zimmer, A Treichel, D Kubein-Messenburg
Journal of Neurochemistry|November 3, 1998
Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-beta1 in cultured rat astrocytesJ A Treichel, M Reddington, G W Kreutzberg
Nature Medicine|October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trialR Dummer, D E Gyorki, J Hyngstrom, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Science News|July 30, 1983
Embryo transfers achieved in humansJ A Treichel
Deutsche Zahnarztliche Zeitschrift|July 1, 1990
[Axiographic irregularities in patients with different clinical function statuses]B Zimmer, A Treichel, D Kubein-Messenburg
Journal of Neurochemistry|November 3, 1998
Regulation of plasminogen activator inhibitor-1 mRNA accumulation by basic fibroblast growth factor and transforming growth factor-beta1 in cultured rat astrocytesJ A Treichel, M Reddington, G W Kreutzberg
Nature Medicine|October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trialR Dummer, D E Gyorki, J Hyngstrom, et al.
Pageof 1